Paracetamol is one of 1026 small molecule programs targeting Coronary Artery Disease. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
Paracetamol
Trodelvy
Tecentriq
DATROWAY
MS Contin
Effexor
Recentin
Zinecard
Avastin
Apatinib Mesylate
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources